… of brand-name medications: Wellbutrin, Lexapro, Cymbalta, Trintellix, Prozac, … that the tuberculosis drug iproniazid was anecdotally … complexity of treatment is the range of antidepressants on … issue of trial-and-error approach to treatment.” Jordan …

… compared with stopping medications abruptly or tapering … Venlafaxine (Effexor) Duloxetine (Cymbalta) Desvenlafaxine (Pristiq) Researchers followed … best treatments to prevent relapse: Continuing the antidepressant without … input from a doctor. Be On the …

… of the drug is Ziac, manufactured by Glenmark Pharmaceuticals Inc., … entirely different prescription drug: ezetimibe, a medication used to … taking Ziac, since stopping treatment suddenly can lead to … Cymbalta Recall Date: Initiated October 9, 2025 Source: FDA …

… FDA was based on two late-stage studies, in which the drug … a number of already-available treatment options for fibromyalgia, including … pregabalin), Eli Lilly's Cymbalta (duloxetine), and AbbVie's … to start a phase 2 trial in major depressive disorder …

… drug is gaining traction as a promising off-label treatment … and blame lack of pharmaceutical investment for impeding its … long list of medications — among them Tramadol, Lyrica, Cymbalta, Fetzima, Mobic … flares. In 2022, her doctor, who had been following …

… an antidepressant, the conversation with the doctor often … trials and 17 reports from the U.S. Food and Drug … with some schizophrenia treatments. The researchers checked … This list includes duloxetine (Cymbalta), venlafaxine (Effexor), desvenlafaxine …

… trials involving 58,534 people. The trials all tracked the effects of the medications … Effexor) and duloxetine (Cymbalta) were all associated … question: which drug suits which person, … treatments themselves." No one should discontinue their antidepressant …

… a big variation between treatments, but SSRIs — or … (SNRIs) like duloxetine (Cymbalta) and tricyclics such as … clinically significant. The trials evaluated in the … tricyclic drugs? The first specific antidepressant drugs, the tricyclic antidepressants (TCAs …

… inhibitor from Vertex Pharmaceuticals, has spurred further … drugs fail, doctors often move to off-label options including antidepressants … biotech’s trials. Axsome is now planning a replacement trial … pivot toward new treatment strategies, including psychedelics …

… diverse range of pharmaceutical options for cancer … the prized brain medications Zyprexa and Cymbalta. Each generated … centers, doctors are experimenting with layered treatment approaches, combining … induced neuropathy. Smaller biotechs also continue to take …